Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Tensor Networks for Latent Variable Analysis: Novel Algorithms for Tensor Train Approximation.

Phan AH, Cichocki A, Uschmajew A, Tichavsky P, Luta G, Mandic DP.

IEEE Trans Neural Netw Learn Syst. 2020 Feb 5. doi: 10.1109/TNNLS.2019.2956926. [Epub ahead of print]

PMID:
32031950
2.

Marketing Influences on Perceptions of Reduced Nicotine Content Cigarettes.

Johnson AC, Mays D, Villanti AC, Niaura RS, Rehberg K, Phan L, Mercincavage M, Luta G, Strasser AA.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S117-S124. doi: 10.1093/ntr/ntz167.

3.

Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study.

Mandelblatt JS, Zhai W, Ahn J, Small BJ, Ahles TA, Carroll JE, Denduluri N, Dilawari A, Extermann M, Graham D, Hurria A, Isaacs C, Jacobsen PB, Jim HSL, Luta G, McDonald BC, Patel SK, Root JC, Saykin AJ, Tometich DB, Zhou X, Cohen HJ.

Cancer. 2019 Dec 20. doi: 10.1002/cncr.32663. [Epub ahead of print]

PMID:
31860135
4.

Culturally Targeted Video Improves Psychosocial Outcomes in Latina Women at Risk of Hereditary Breast and Ovarian Cancer.

Hurtado-de-Mendoza A, Graves KD, Gómez-Trillos S, Carrera P, Campos C, Anderson L, Luta G, Peshkin BN, Schwartz MD, Cupertino AP, Gonzalez N, Sheppard VB.

Int J Environ Res Public Health. 2019 Nov 29;16(23). pii: E4793. doi: 10.3390/ijerph16234793.

5.

Development and Pretesting of Risk-Based Mobile Multimedia Message Content for Young Adult Hookah Use.

Johnson AC, Lipkus I, Tercyak KP, Luta G, Rehberg K, Phan L, Abroms LC, Mays D.

Health Educ Behav. 2019 Dec;46(2_suppl):97-105. doi: 10.1177/1090198119874841.

PMID:
31742460
6.

Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.

Hoffman RM, Lobo T, Van Den Eeden SK, Davis KM, Luta G, Leimpeter AD, Aaronson D, Penson DF, Taylor K.

Med Decis Making. 2019 Nov;39(8):962-974. doi: 10.1177/0272989X19883242. Epub 2019 Oct 21.

PMID:
31631745
7.

Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype.

Carroll JE, Small BJ, Tometich DB, Zhai W, Zhou X, Luta G, Ahles TA, Saykin AJ, Nudelman KNH, Clapp JD, Jim HS, Jacobsen PB, Hurria A, Graham D, McDonald BC, Denduluri N, Extermann M, Isaacs C, Dilawari AA, Root J, Stern RA, Mandelblatt JS; Thinking and Living With Cancer Study.

Cancer. 2019 Dec 15;125(24):4516-4524. doi: 10.1002/cncr.32489. Epub 2019 Sep 25.

PMID:
31553501
8.

Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial.

Taylor KL, Deros DE, Fallon S, Stephens J, Kim E, Lobo T, Davis KM, Luta G, Jayasekera J, Meza R, Stanton CA, Niaura RS, Abrams DB, McKee B, Howell J, Ramsaier M, Batlle J, Dornelas E, Parikh V, Anderson E.

Contemp Clin Trials. 2019 Jul;82:25-35. doi: 10.1016/j.cct.2019.05.006. Epub 2019 May 23.

9.

Analyzing outliers: robust methods to the rescue.

Greco L, Luta G, Krzywinski M, Altman N.

Nat Methods. 2019 Apr;16(4):275-276. doi: 10.1038/s41592-019-0369-z. No abstract available.

PMID:
30923374
10.

Variance Estimation and Confidence Intervals for 11 Commonly Used Health Disparity Measures.

Ahn J, Harper S, Yu M, Feuer EJ, Liu B, Luta G.

JCO Clin Cancer Inform. 2018 Dec;2:1-19. doi: 10.1200/CCI.18.00031.

11.

Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors.

Tometich DB, Small BJ, Carroll JE, Zhai W, Luta G, Zhou X, Kobayashi LC, Ahles T, Saykin AJ, Clapp JD, Jim HSL, Jacobsen PB, Hurria A, Graham D, McDonald BC, Denduluri N, Extermann M, Isaacs C, Dilawari A, Root J, Rini C, Mandelblatt JS; Thinking and Living with Cancer (TLC) Study.

J Pain Symptom Manage. 2019 Mar;57(3):596-606. doi: 10.1016/j.jpainsymman.2018.11.015. Epub 2018 Nov 23.

PMID:
30472317
12.

Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.

Mandelblatt JS, Small BJ, Luta G, Hurria A, Jim H, McDonald BC, Graham D, Zhou X, Clapp J, Zhai W, Breen E, Carroll JE, Denduluri N, Dilawari A, Extermann M, Isaacs C, Jacobsen PB, Kobayashi LC, Holohan Nudelman K, Root J, Stern RA, Tometich D, Turner R, VanMeter JW, Saykin AJ, Ahles T.

J Clin Oncol. 2018 Oct 3:JCO1800140. doi: 10.1200/JCO.18.00140. [Epub ahead of print]

PMID:
30281396
13.

Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer.

Jayasekera J, Schechter CB, Sparano JA, Jagsi R, White J, Chapman JW, Whelan T, Anderson SJ, Fyles AW, Sauerbrei W, Zellars RC, Li Y, Song J, Huang X, Julian TB, Luta G, Berry DA, Feuer EJ, Mandelblatt J; CISNET-BOLD Collaborative Group.

J Natl Cancer Inst. 2018 Dec 1;110(12):1370-1379. doi: 10.1093/jnci/djy128.

14.

Statistical mistakes and how to avoid them - lessons learned from the reproducibility crisis.

Turkiewicz A, Luta G, Hughes HV, Ranstam J.

Osteoarthritis Cartilage. 2018 Nov;26(11):1409-1411. doi: 10.1016/j.joca.2018.07.017. Epub 2018 Aug 8. No abstract available.

15.

Incidence of childhood cancer in Costa Rica, 2000-2014: An international perspective.

Erdmann F, Li T, Luta G, Giddings BM, Torres Alvarado G, Steliarova-Foucher E, Schüz J, Mora AM.

Cancer Epidemiol. 2018 Oct;56:21-30. doi: 10.1016/j.canep.2018.07.004. Epub 2018 Jul 18.

PMID:
30025251
16.

Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.

Jayasekera J, Li Y, Schechter CB, Jagsi R, Song J, White J, Luta G, Chapman JW, Feuer EJ, Zellars RC, Stout N, Julian TB, Whelan T, Huang X, Shelley Hwang E, Hopkins JO, Sparano JA, Anderson SJ, Fyles AW, Gray R, Sauerbrei W, Mandelblatt J, Berry DA; CISNET-BOLD Collaborative Group.

J Natl Cancer Inst. 2018 Dec 1;110(12):1360-1369. doi: 10.1093/jnci/djy059.

17.

The Impact of Using Different Reference Populations on Measurement of Breast Cancer-Related Cognitive Impairment Rates.

Clapp JD, Luta G, Small BJ, Ahles TA, Root JC, Graham D, Hurria A, Jacobsen PB, Jim H, McDonald BC, Stern RA, Saykin AJ, Mandelblatt JS; Thinking and Living with Cancer (TLC) Study.

Arch Clin Neuropsychol. 2018 Dec 1;33(8):956-963. doi: 10.1093/arclin/acx142.

18.

Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study.

Taylor KL, Luta G, Hoffman RM, Davis KM, Lobo T, Zhou Y, Leimpeter A, Shan J, Jensen RE, Aaronson DS, Van Den Eeden SK.

Transl Behav Med. 2018 Mar 1;8(2):156-165. doi: 10.1093/tbm/ibx005.

19.

Modeling risk for developing drug resistant bacterial infections in an MDR-naive critically ill population.

Sonti R, Conroy ME, Welt EM, Hu Y, Luta G, Jamieson DB.

Ther Adv Infect Dis. 2017 Jul;4(4):95-103. doi: 10.1177/2049936117715403. Epub 2017 Jul 5.

20.

Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).

Bluethmann SM, Alfano CM, Clapp JD, Luta G, Small BJ, Hurria A, Cohen HJ, Sugarman S, B Muss H, Isaacs C, Mandelblatt JS.

Breast Cancer Res Treat. 2017 Oct;165(3):677-686. doi: 10.1007/s10549-017-4353-y. Epub 2017 Jun 26.

21.

Decision-making processes among men with low-risk prostate cancer: A survey study.

Hoffman RM, Van Den Eeden SK, Davis KM, Lobo T, Luta G, Shan J, Aaronson D, Penson DF, Leimpeter AD, Taylor KL.

Psychooncology. 2018 Jan;27(1):325-332. doi: 10.1002/pon.4469. Epub 2017 Jul 13.

22.

United States Population-Based Estimates of Patient-Reported Outcomes Measurement Information System Symptom and Functional Status Reference Values for Individuals With Cancer.

Jensen RE, Potosky AL, Moinpour CM, Lobo T, Cella D, Hahn EA, Thissen D, Smith AW, Ahn J, Luta G, Reeve BB.

J Clin Oncol. 2017 Jun 10;35(17):1913-1920. doi: 10.1200/JCO.2016.71.4410. Epub 2017 Apr 20.

23.

Control of confounding in the analysis phase - an overview for clinicians.

Kahlert J, Gribsholt SB, Gammelager H, Dekkers OM, Luta G.

Clin Epidemiol. 2017 Mar 31;9:195-204. doi: 10.2147/CLEP.S129886. eCollection 2017.

24.

Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).

Mandelblatt JS, Cai L, Luta G, Kimmick G, Clapp J, Isaacs C, Pitcher B, Barry W, Winer E, Sugarman S, Hudis C, Muss H, Cohen HJ, Hurria A.

Breast Cancer Res Treat. 2017 Jul;164(1):107-117. doi: 10.1007/s10549-017-4222-8. Epub 2017 Mar 31.

25.

A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.

Knerr S, Wernli KJ, Leppig K, Ehrlich K, Graham AL, Farrell D, Evans C, Luta G, Schwartz MD, O'Neill SC.

Contemp Clin Trials. 2017 May;56:25-33. doi: 10.1016/j.cct.2017.02.009. Epub 2017 Feb 28.

26.

Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance).

Durá-Ferrandis E, Mandelblatt JS, Clapp J, Luta G, Faul L, Kimmick G, Cohen HJ, Yung RL, Hurria A.

Psychooncology. 2017 Nov;26(11):1914-1921. doi: 10.1002/pon.4404. Epub 2017 Mar 9.

27.

Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial.

Taylor KL, Hagerman CJ, Luta G, Bellini PG, Stanton C, Abrams DB, Kramer JA, Anderson E, Regis S, McKee A, McKee B, Niaura R, Harper H, Ramsaier M.

Lung Cancer. 2017 Jun;108:242-246. doi: 10.1016/j.lungcan.2017.01.020. Epub 2017 Feb 15.

28.

Risk of serious adverse effects of biological and targeted drugs in patients with rheumatoid arthritis: a systematic review meta-analysis.

Tarp S, Eric Furst D, Boers M, Luta G, Bliddal H, Tarp U, Heller Asmussen K, Brock B, Dossing A, Schjødt Jørgensen T, Thirstrup S, Christensen R.

Rheumatology (Oxford). 2017 Mar 1;56(3):417-425. doi: 10.1093/rheumatology/kew442. Review.

PMID:
28013201
29.

Leveraging the test effect to improve maintenance of the gains achieved through cognitive rehabilitation.

Friedman RB, Sullivan KL, Snider SF, Luta G, Jones KT.

Neuropsychology. 2017 Feb;31(2):220-228. doi: 10.1037/neu0000318. Epub 2016 Oct 10.

30.

Metabolomic profiling of breast tumors using ductal fluid.

Matos Do Canto L, Marian C, Varghese RS, Ahn J, Da Cunha PA, Willey S, Sidawy M, Rone JD, Cheema AK, Luta G, Nezami Ranjbar MR, Ressom HW, Haddad BR.

Int J Oncol. 2016 Dec;49(6):2245-2254. doi: 10.3892/ijo.2016.3732. Epub 2016 Oct 13.

31.

Empirical Likelihood-Based ANOVA for Trimmed Means.

Velina M, Valeinis J, Greco L, Luta G.

Int J Environ Res Public Health. 2016 Sep 27;13(10). pii: E953.

32.

Objective support for subjective reports of successful inner speech in two people with aphasia.

Hayward W, Snider SF, Luta G, Friedman RB, Turkeltaub PE.

Cogn Neuropsychol. 2016 Jul-Sep;33(5-6):299-314. doi: 10.1080/02643294.2016.1192998. Epub 2016 Jul 29.

33.

Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).

Mandelblatt JS, Clapp JD, Luta G, Faul LA, Tallarico MD, McClendon TD, Whitley JA, Cai L, Ahles TA, Stern RA, Jacobsen PB, Small BJ, Pitcher BN, Dura-Fernandis E, Muss HB, Hurria A, Cohen HJ, Isaacs C.

Cancer. 2016 Nov 15;122(22):3555-3563. doi: 10.1002/cncr.30208. Epub 2016 Jul 22.

34.

Generalized Confidence Intervals and Fiducial Intervals for Some Epidemiological Measures.

Bebu I, Luta G, Mathew T, Agan BK.

Int J Environ Res Public Health. 2016 Jun 18;13(6). pii: E605. doi: 10.3390/ijerph13060605.

35.

Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.

Taylor KL, Hoffman RM, Davis KM, Luta G, Leimpeter A, Lobo T, Kelly SP, Shan J, Aaronson D, Tomko CA, Starosta AJ, Hagerman CJ, Van Den Eeden SK.

Cancer Epidemiol Biomarkers Prev. 2016 Aug;25(8):1240-50. doi: 10.1158/1055-9965.EPI-15-1079. Epub 2016 Jun 2.

36.

Applications of a Novel Clustering Approach Using Non-Negative Matrix Factorization to Environmental Research in Public Health.

Fogel P, Gaston-Mathé Y, Hawkins D, Fogel F, Luta G, Young SS.

Int J Environ Res Public Health. 2016 May 18;13(5). pii: E509. doi: 10.3390/ijerph13050509.

37.

Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management.

Kelly SP, Van Den Eeden SK, Hoffman RM, Aaronson DS, Lobo T, Luta G, Leimpter AD, Shan J, Potosky AL, Taylor KL.

J Urol. 2016 Sep;196(3):734-40. doi: 10.1016/j.juro.2016.04.045. Epub 2016 Apr 14.

38.

A Simulation-Based Comparison of Covariate Adjustment Methods for the Analysis of Randomized Controlled Trials.

Chaussé P, Liu J, Luta G.

Int J Environ Res Public Health. 2016 Apr 11;13(4):414. doi: 10.3390/ijerph13040414.

39.
40.

Predictors of improvement in observed functional ability in patients with fibromyalgia as an outcome of rehabilitation.

Amris K, Luta G, Christensen R, Danneskiold-Samsøe B, Bliddal H, Wæhrens EE.

J Rehabil Med. 2016 Jan;48(1):65-71. doi: 10.2340/16501977-2036.

41.

Birth order and risk of childhood cancer in the Danish birth cohort of 1973-2010.

Schüz J, Luta G, Erdmann F, Ferro G, Bautz A, Simony SB, Dalton SO, Lightfoot T, Winther JF.

Cancer Causes Control. 2015 Nov;26(11):1575-82. doi: 10.1007/s10552-015-0651-z. Epub 2015 Aug 11.

PMID:
26259524
42.

Decisional outcomes following use of an interactive web-based decision aid for prostate cancer screening.

Tomko C, Davis K, Ludin S, Kelly S, Stern A, Luta G, Taylor KL.

Transl Behav Med. 2015 Jun;5(2):189-97. doi: 10.1007/s13142-014-0301-0.

43.

Adherence to methotrexate in rheumatoid arthritis: a danish nationwide cohort study.

Bliddal H, Eriksen SA, Christensen R, Lorenzen T, Hansen MS, Østergaard M, Dreyer L, Luta G, Vestergaard P.

Arthritis. 2015;2015:915142. doi: 10.1155/2015/915142. Epub 2015 Feb 25.

44.

Baseline Attitudes About Prostate Cancer Screening Moderate the Impact of Decision Aids on Screening Rates.

Starosta AJ, Luta G, Tomko CA, Schwartz MD, Taylor KL.

Ann Behav Med. 2015 Oct;49(5):762-8. doi: 10.1007/s12160-015-9692-5.

45.

E-Cigarettes and Smoking Cessation: Insights and Cautions From a Secondary Analysis of Data From a Study of Online Treatment-Seeking Smokers.

Pearson JL, Stanton CA, Cha S, Niaura RS, Luta G, Graham AL.

Nicotine Tob Res. 2015 Oct;17(10):1219-27. doi: 10.1093/ntr/ntu269. Epub 2014 Dec 26.

46.

Mediation analysis of gestational age, congenital heart defects, and infant birth-weight.

Wogu AF, Loffredo CA, Bebu I, Luta G.

BMC Res Notes. 2014 Dec 17;7:926. doi: 10.1186/1756-0500-7-926.

47.

Motivators and barriers to Latinas' participation in clinical trials: the role of contextual factors.

London L, Hurtado-de-Mendoza A, Song M, Nagirimadugu A, Luta G, Sheppard VB.

Contemp Clin Trials. 2015 Jan;40:74-80. doi: 10.1016/j.cct.2014.11.013. Epub 2014 Nov 26.

48.

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.

Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, Graves K, Feeley L, Isaacs C, Valdimarsdottir HB, Jandorf L, DeMarco T, Wood M, McKinnon W, Garber J, McCormick SR, Schwartz MD.

Genet Med. 2015 Jun;17(6):467-75. doi: 10.1038/gim.2014.125. Epub 2014 Sep 18.

49.

A comparison of web-based versus print-based decision AIDS for prostate cancer screening: participants' evaluation and utilization.

Tomko C, Davis KM, Luta G, Krist AH, Woolf SH, Taylor KL.

J Gen Intern Med. 2015 Jan;30(1):33-42. doi: 10.1007/s11606-014-2994-7. Epub 2014 Sep 3.

50.

Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data.

Mandelblatt JS, Huang K, Makgoeng SB, Luta G, Song JX, Tallarico M, Roh JM, Munneke JR, Houlston CA, McGuckin ME, Cai L, Clarke Hillyer G, Hershman DL, Neugut AI, Isaacs C, Kushi L.

J Oncol Pract. 2015 Jan;11(1):e1-8. doi: 10.1200/JOP.2013.001288. Epub 2014 Aug 26.

Supplemental Content

Support Center